Navigation Links
Preemies Exposed to Toxins in Liquid Meds
Date:1/23/2009

Called excipients, these agents include chemicals that can cause nerve damage, study says

FRIDAY, Jan. 23 (HealthDay News) -- Potentially harmful agents called excipients are contained in liquid medicines commonly given to premature infants, according to a U.K. study.

Excipients are used to ease the administration, absorption or preservation of the active substances or to improve the taste and appearance of the liquid medicines, according to background information in the study.

The British researchers assessed the type and content of liquid medicines given to 38 premature babies in a neonatal intensive care unit. The babies were treated for between 2.5 weeks and nine weeks and given a range of treatments, including iron, vitamin drops, furosemide and fexamethasone.

During their treatment, the infants were regularly exposed to 20 different excipients, including ethanol (found in iron and furosemide) and propylene glycol (found in dexamethasone). These chemicals can cause nerve damage.

The infants' exposure to ethanol ranged from 0.2 ml to 1.8 ml a week, equivalent to one to seven units of alcohol, while exposure to sorbitol (dexamethasone and iron) ranged from 0.1 to 3.5 g/week. The recommended maximum intake of sorbitol for adults is 20 g/day. When calculated by weight, this level was exceeded in 18 babies for at least one week. The study also found that all babies given dexamethasone exceeded the recommended levels of propylene glycol, which is about two-thirds the strength of ethanol.

The seven infants with severe lung disease were exposed to higher levels of excipients than the other premature babies.

The findings were published in the Fetal & Neonatal Editions of Archives of Disease in Childhood.

It's difficult for makers of children's medicines to tailor their products for each age group, and the use of some excipients is necessary, the study authors noted. However, they concluded: "We feel it is important that the [medicines regulators] not only ensure that all manufacturers provide detailed labeling of the excipient content of their products but all lead action to determine whether existing practice constitutes a risk, and if so, how this might be dealt with."

More information

The U.S. National Institute of Child Health and Human Development has more about preterm labor and birth.



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, Jan. 20, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Sepsis Therapy in Preemies Fails to Boost Survival
2. Multiple Doses of Steroids Dont Help Preemies
3. Preemies Low Blood Pressure Linked to SIDS
4. Drugs to Treat Lung Damage in Preemies May Harm Brain
5. Steroid treatment offers no benefit in preemies, Hopkins Childrens study suggests
6. Epsom Salt Cut Cerebral Palsy Rate in Half Among Preemies
7. Tel Aviv University gives preemies a fighting chance
8. Caffeine Therapy Boosts Preemies Outcomes
9. Recovery coaches effective in reducing number of babies exposed to drugs
10. Almost Half of Kids Still Exposed to Secondhand Smoke
11. Newborns exposed to maternal smoking more irritable, difficult to soothe
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Preemies Exposed to Toxins in Liquid Meds
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth has organized ... protect parental rights and civil liberties, and to restore transparency within government agencies ... coincides with a press conference taking place Friday morning calling on President Trump ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... and services, is proud to announce it has joined the National Association for ... the interests of chronically ill, disabled, and dying Americans of all ages and ...
(Date:3/28/2017)... ... 2017 , ... Z-Medica, LLC, a leading developer and marketer ... will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 schools ... by the American College of Surgeons, U.S. Department of Defense, Department of Homeland ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 2017 , ... With less than 10,000 dermatologists in the United States and ... limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... online, today released its inaugural survey on the State of Acne in America. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
Breaking Medicine Technology: